Ankr - Cancer Care Companion
By Ankr Health
Ankr is a cancer education and navigation app for iOS that provides clinical trial databases and care coordination tools for patients and their families.
The App DNA
What makes this app unique?
The platform removes the cognitive load of managing complex treatment information by centralizing clinical data and communication with care teams in one location.
For Cancer patients and their caregivers seeking organized treatment navigation and secure communication tools for their medical teams.
What does it look like?
Key features
Algorithm suggests treatment paths based on national guidelines and doctor preferences, driving trust through clinical authority.
Provides searchable access to clinical trials specific to cancer types, serving as a primary acquisition hook.
Enables sharing of medication lists and side-effect tracking, acting as a B2B integration hook for health systems.
How much does it cost?
The freemium model gates high-touch support and education events behind a Pro subscription, while keeping core navigation tools free to maximize user acquisition.
Velocity
Dormant developmentShow more...
Ankr - Cancer Care Companion has seen no development activity for 2,068 days. The app remains in a state of total stagnation with no updates or feature additions since its initial release. Given the lack of activity over the last several years, the development momentum is classified as inactive.
Who built it?
Ankr Health
2 apps tracked · Health & Fitness
Sol - AI Medical ScribeUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Ankr - Cancer Care Companion
How's the Health & Fitness market?
Ankr maintains a niche position in the health-fitness category, though its lack of updates since 2021 limits its competitive standing. The absence of recent activity suggests the platform is no longer actively competing for new user acquisition.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Ankr - Cancer Care Companion
Where is it heading?
The health-tech market is consolidating around platforms that offer real-time, updated clinical guidance and secure, modern data handling. Ankr's failure to update since 2021 leaves it exposed to security risks and feature parity gaps, meaning the PM should shift focus to B2B data licensing to salvage the remaining asset value.
- The five-year development silence indicates the product is in a zombie state, which erodes trust for health-related tools.
- Active competitors are integrating navigation features into modern, updated platforms, rendering static tools like Ankr obsolete for new users.
The SWOT
- Clinical trial database provides high-value utility for patients
- Licensing the clinical trial database to partner health systems
Next best moves
Sunset the consumer-facing app because the five-year development gap makes it a liability → reduce brand risk
+ 1 more prioritized moveThe counter-intuitive read
The lack of updates is not a failure…
Read the full takeBottom line
Ankr's clinical trial database offers clear utility, but the five-year development silence makes it a high-risk tool for patient care. The PM should pivot toward a B2B licensing model to capture value without requiring further consumer-facing maintenance.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated